(Q40105232)

17 September 2017

EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number (English)

1 reference

17 September 2017

1 reference

M A Kim

1

1 reference

17 September 2017

H S Lee

2

1 reference

17 September 2017

H E Lee

3

1 reference

17 September 2017

Y K Jeon

4

1 reference

17 September 2017

H K Yang

5

1 reference

17 September 2017

W H Kim

6

1 reference

17 September 2017

5 April 2008

1 reference

17 September 2017

1 reference

17 September 2017

52

1 reference

17 September 2017

738-746

1 reference

17 September 2017

6

1 reference

Characterization of epidermal growth factor receptor gene expression in malignant and normal human cell lines

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Epidermal growth factor receptor (EGFR) signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Epidermal growth factor receptor expression and gene amplification in colorectal carcinoma: an immunohistochemical and chromogenic in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

The role of adjuvant monoclonal antibody therapy for breast cancer: rationale and new studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Amplification and overexpression of the EGF receptor and c-erbB-2 proto-oncogenes in human stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Critical update and emerging trends in epidermal growth factor receptor targeting in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

The epidermal growth factor receptor gene sequence is highly conserved in primary gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

Pharmacodynamic Studies of Gefitinib in Tumor Biopsy Specimens From Patients With Advanced Gastric Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2008.03021.X

10.1111/J.1365-2559.2008.03021.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference